Archive for January, 2007

On January 18, the Commission announced its challenge to Hospira Inc.’s (“Hospira”) proposed $2 billion acquisition of rival drug manufacturer Mayne Pharma Ltd. (“Mayne”), along with an agreement and order requiring the companies to sell assets used to manufacture and supply five generic injectable pharmaceuticals in order for the transaction […]

On January 17, testifying before the Senate Committee on the Judiciary on the subject of anticompetitive patent settlements in the U.S. pharmaceutical industry, FTC Commissioner Jon Leibowitz said that recent court cases have made it more difficult to bring antitrust cases to stop exclusion payment settlements between brand manufacturers and […]

On January 9, the Commission received a petition from Service Corporation International (SCI) and Alderwoods Group, Inc. seeking approval to divest the properties listed below under three sale agreements, to KAG, LLC, which, prior to the closing of the transaction, will be a subsidiary of NorthStar Memorial Group, LLC. The […]

On January 8th, a payment processor violated federal law when it debited, or tried to debit, more than $9.9 million from consumers’ bank accounts – at $139 each – without their approval. According to a complaint the FTC filed in federal court, Nevada-based InterBill Ltd. acted on behalf of a […]

On January 5, the Commission received a petition from Service Corporation International (SCI) and Alderwoods Group, Inc. seeking approval to divest a range of funeral home and cemetery services companies. Through this petition, a public version of which can be found on the Commission’s Web site as a link to […]

The FTC filed complaints on January 4th, in four separate cases alleging that weight-loss and weight-control claims were not supported by competent and reliable scientific evidence. Marketers of the four products -Xenadrine EFX, CortiSlim, TrimSpa, and One-A-Day WeightSmart -settled with the FTC, surrendered cash and other assets worth at least […]

For More Information Please Contact Us At:

About Our Law Firm:

Doyle, Barlow & Mazard PLLC ("DBM") was founded in April 2006. Our goal is to provide personalized, high quality legal services for every client.

Practice Areas

DBM provides regulatory counseling to domestic and international companies and financial institutions seeking advice regarding private and government antitrust investigations and litigation, including merger and acquisition matters, international trade issues and a broad array of hospitality matters.